Improved Glycemic Control: For patients with type 2 diabetes or prediabetes, Semaglutide not only aids in weight loss but also helps improve blood sugar levels, making it a dual-benefit treatment
More insurance companies are now covering name-brand GLP-1s, but often with additional eligibility restrictions
Semaglutide has been structurally modified to resist degradation by the enzyme DPP-4 and to bind to albumin, extending its half-life from approximately two minutes for natural GLP-1 to about one week
The approach works from the bottom up
However, the first dose (0.25 mg) is a low introductory dose, so noticeable effects may be subtle initially
[DOI] [PMC free article] [PubMed] [Google Scholar] 124.Leow Z.Z.X., Guelfi K.J., Davis E.A., Jones T.W., Fournier P.A